Lakhmir S. Chawla

CIK: 0001646626

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REVB

REVELATION BIOSCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

REVB
REVELATION BIOSCIENCES, INC.
Aug 17, 2026
Award(A)
Direct
32K shares-
REVB
REVELATION BIOSCIENCES, INC.
Feb 3, 2026
Tax Payment(F)
Direct
2.3K shares at avg. $1.85$4K
REVB
REVELATION BIOSCIENCES, INC.
Jan 8, 2026
Award(A)
Direct
42K shares at avg. $0.90$38K
REVB
REVELATION BIOSCIENCES, INC.
Oct 29, 2025
Award(A)
Direct
15.6K shares at avg. $1.28$20K
REVB
REVELATION BIOSCIENCES, INC.
Feb 11, 2025
Award(A)
Direct
181 shares at avg. $3.87$700.47

		Type	Shares	Price		Ownership
Aug 17, 2026	REVB REVELATION BIOSCIENCES, INC.	Award(A)	32,011	-	$0	Direct
Feb 3, 2026	REVB REVELATION BIOSCIENCES, INC.	Tax Payment(F)	2,261	$1.85	$4,183	Direct
Jan 8, 2026	REVB REVELATION BIOSCIENCES, INC.	Award(A)	41,981	$0.90	$37,783	Direct
Oct 29, 2025	REVB REVELATION BIOSCIENCES, INC.	Award(A)	15,625	$1.28	$20,000	Direct
Feb 11, 2025	REVB REVELATION BIOSCIENCES, INC.	Award(A)	181	$3.87	$700	Direct

1-5 of 5 transactions

About Chawla Lakhmir S

Chawla Lakhmir S (SEC CIK 0001646626) files insider reports with the SEC as Director of REVELATION BIOSCIENCES, INC. (REVB).

Signal8 holds 5 ownership filings by Chawla Lakhmir S, all Form 4s, filed between Feb 13, 2025 and Aug 18, 2026. Those filings report 5 transactions, from Feb 11, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chawla Lakhmir S's filings is in SAN DIEGO, CA.

Recent filings by Chawla Lakhmir S

Aug 17, 2026: Grant or award of REVB shares (Form 4, code A).
Feb 3, 2026: Tax withholding of REVB shares (Form 4, code F).
Jan 8, 2026: Grant or award of REVB shares (Form 4, code A).
Oct 29, 2025: Grant or award of REVB shares (Form 4, code A).
Feb 11, 2025: Grant or award of REVB shares (Form 4, code A).

Other insiders filing for REVELATION BIOSCIENCES, INC. (REVB)

Rolke James, Chief Executive Officer
Zygmont Chester Stanley III, Chief Financial Officer
ROPER JESS, Director
CARVER JENNIFER, Director
TIDMARSH GEORGE F, Director

How to read Form 4 transaction codes